GeneCellNano

GeneCellNano, a Finnish biotechnology company, develops new biological drugs, biomarkers, and diagnostics for diseases with unmet clinical need, headquartered in Finland.

Here are key aspects of the company:

• Products & Services: The organization creates Advanced Therapy Medicinal Products (ATMP), biomarkers, and diagnostics specifically targeting cardiovascular diseases, age-related macular degeneration, and various cancers including brain, ovarian, and bladder cancer.
• Industries: Operations focus on the intersection of biological medicine and nanotechnology to address complex health challenges through interdisciplinary research.
• Innovation: The company utilizes a new method that improves nanoscale particle separation and purification while fostering an ecosystem supported by Business Finland Leading Company initiatives.

GeneCellNano stands as a premier interdisciplinary hub in Finland, uniting top experts to advance biological therapies and nanotechniques for critical medical applications.